Raymond Yu

Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model

B. Edil, T. Liang, elliot k fishman, 2022, Cancer letters.

RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease

N. Shenoy, P. Young, N. Wong, 2017, Molecular Pharmacology.

A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice.

P. Young, N. Wong, K. McLure, 2014, Atherosclerosis.